770 Results for "

Ppar

" in MedChemExpress (MCE) Product Catalog:
Products (770)

770 Results for "Ppar" in MCE Product Catalog:

  • Targets Recommended:
20
20 Cited Publications
Cat. No.: HY-B2163
CAS No.: 472-61-7
Astaxanthin, the red dietary carotenoid, is an orally effective and potent antioxidant. Astaxanthin inhibits NF-κB and down-regulates VEGF in blood glucose. Astaxanthin exerts anti-cancer cell proliferation, increases apoptosis, impairs migration and invasion by activating PPARγ and reducing the expression of STAT3. Astaxanthin also has neuroprotective and anti-inflammatory activity and can be used in studies of cancer, diabetic retinopathy, cardiovascular disease, and in the coloring of animal feed .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-13928
CAS No.: 317318-84-6
Purity:  99.94%
Synonyms: GW610742
GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, 1.1 μM and 2 μM for human PPARδ, PPARα, and PPARγ, respectively.
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-15577
CAS No.: 188591-46-0
Purity:  98.11%
Target:  

PPAR

Research Areas:  

Cancer

GSK3787 is a selective and irreversible peroxisome proliferator-activated receptor δ (PPARδ) antagonist with pIC50 of 6.6.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-16737
CAS No.: 923978-27-2
Synonyms: GFT505
Target:  

PPAR

Elafibranor (GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. Elafibranor can be used for the study of primary biliary cholangitis .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-123986
CAS No.: 68003-38-3
Purity:  99.95%
Research Areas:  

Inflammation/Immunology Cancer

CTPI-2 is a third-generation mitochondrial citrate carrier SLC25A1 inhibitor with a KD of 3.5 μM. CTPI-2 inhibits glycolysis, PPARγ, and its downstream target the glucose transporter GLUT4. CTPI-2 halts salient alterations of NASH reverting steatosis, preventing the evolution to steatohepatitis, reducing inflammatory macrophage infiltration in the liver and adipose tissue, and starkly mitigating obesity induced by a high-fat diet. Antitumor activity .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-B0637
CAS No.: 41859-67-0
Synonyms: BM15075
Target:  

PPAR

Bezafibrate is an agonist of PPAR, with EC50s of 50 μM, 60 μM, 20 μM for human PPARα, PPARγ and PPARδ, and 90 μM, 55 μM, 110 μM for murine PPARα, PPARγ and PPARδ, respectively; Bezafibrate is used as an hypolipidemic agent.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-12377
CAS No.: 1014691-61-2
Purity:  99.49%
Target:  

PPAR

Research Areas:  

Metabolic Disease

GSK0660 is a potent PPARβ antagonist with an IC50 of 155 nM.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-B0140
CAS No.: 317-34-0
Aminophylline is a competitive phosphodiesterase 3/4 (PDE3/4) inhibitor. Aminophylline also acts as an adenosine receptor antagonist. Aminophylline elevates intracellular cAMP levels via competitive inhibition of PDE3 and PDE4, antagonizes adenosine A1 receptor (ADORA1), regulates intracellular calcium signaling and synaptic vesicle cycling, upregulates the PPAR signaling pathway, and downregulates glutamatergic synaptic pathways simultaneously. Aminophylline can be used in research related to major depressive disorder, epilepsy, asthma, and chronic obstructive pulmonary disease (COPD) .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-14166
CAS No.: 118414-82-7
Purity:  99.87%
Synonyms: L 663536
Research Areas:  

Cancer

MK-886 (L 663536) is a potent, cell-permeable and orally active FLAP (IC50 of 30 nM) and leukotriene biosynthesis (IC50s of 3 nM and 1.1 μM in intact leukocytes and human whole blood, respectively) inhibitor. MK-886 is also a non-competitive PPARα antagonist and can induce apoptosis .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-15655
CAS No.: 196808-24-9
Purity:  99.93%
Target:  

PPAR

GW 1929 is an orally active peroxisome proliferator-activated receptor-γ (PPARγ) agonist with a pKi of 8.84 for human PPAR-γ, and pEC50s of 8.56 and 8.27 for human PPAR-γ and murine PPAR-γ, respectively. GW 1929 (hydrochloride) has antidiabetic efficacy and neuroprotective potential .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-N0393
CAS No.: 59870-68-7
Glabridin is a natural isoflavan from Glycyrrhiza glabra L., binds to and activates PPARγ, with an EC50 of 6115 nM. Glabridin exhibits antioxidant, anti-bacterial, anti-nephritic, anti-diabetic, anti-fungal, antitumor, anti-inflammatory, antiosteoporotic, cardiovascular protective, neuroprotective and radical scavenging activities .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15725
CAS No.: 443104-02-7
Purity:  99.30%
Synonyms: RTA-403; TP-235; CDDO-Imidazolide
Research Areas:  

Cancer

CDDO-Im (RTA-403) is an activator of Nrf2 and PPAR, with Kis of 232 and 344 nM for PPARα and PPARγ .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-N0234
CAS No.: 19879-30-2
Synonyms: 7-O-Methylbavachin; Bavachinin A
Bavachinin is agonist of pan-peroxisome proliferator-activated receptor (PPAR), with the IC50 value of 21.043 μM, 12.819 μM, and 0.622 μM to PPAR-α, RRAR-β/δ, and PPAR-γ, respectively. Bavachinin is an inhibitor of HIF-1α. Bavachinin exhibits antitumor activity against non-small cell lung cancer by targeting RRAR-γ. Bavachinin is a natural compound with anti-inflammatory and anti-angiogenic activities. Bavachinin has orally bioactivity. .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-19937
CAS No.: 495399-09-2
Target:  

PPAR

Research Areas:  

Metabolic Disease

Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-19937A
CAS No.: 1639792-20-3
Target:  

PPAR

Research Areas:  

Metabolic Disease

Saroglitazar magnesium is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-17618
CAS No.: 848259-27-8
Synonyms: (R)-K-13675
Pemafibrate is a highly selective PPARα agonist, with an EC50 of 1 nM.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-N0222
CAS No.: 572-30-5
Avicularin is an orally active flavonoid. Avicularin inhibits NF-κB (p65), COX-2 and PPAR-γ activities. Avicularin has anti-inflammatory, anti-infectious anti-allergic, anti-oxidant, hepatoprotective, and anti-tumor activities .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-N0292
CAS No.: 32619-42-4
Oleuropein, found in olive leaves and oil, exerts antioxidant, anti-inflammatory and anti-atherogenic effects through direct inhibition of PPARγ transcriptional activity . Oleuropein induces apoptosis in breast cancer cells via the p53-dependent pathway and through the regulation of Bax and Bcl2 genes. Oleuropein also inhibits aromatase .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-N0163
CAS No.: 528-43-8
Magnolol, a natural lignan isolated from the stem bark of Magnolia officinalis, is a dual agonist of both RXRα and PPARγ, with EC50 values of 10.4 µM and 17.7 µM, respectively.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-N0625A
CAS No.: 36052-37-6
Alpinetin is a flavonoid isolated from cardamom and possesses antitumor, antiinflammation, hepatoprotective, cardiovascular protective, lung protective, antibacterial, antiviral, neuroprotective properties. Alpinetin inhibits lipopolysaccharide (LPS)-induced inflammation, activates PPAR-γ, activates Nrf2, and inhibits TLR4 expression to protect LPS-induced renal injury .
loading...
    loading...